IL1B and major depressive disorder: Therefore, we hypothesized that IL1β derived from mononuclear lysates might better discern MDD patients from controls compared with plasma IL1β and that baseline lysate IL1β levels or their changes over antidepressant treatment might more efficiently discriminate responders from non-responders.